To include your compound in the COVID-19 Resource Center, submit it here.

Breo Ellipta fluticasone furoate/vilanterol regulatory update

FDA approved an sNDA for Breo Ellipta fluticasone furoate/vilanterol from GlaxoSmithKline and Theravance as a once-daily maintenance

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE